This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Certainly! Here is the article about inventor Maria Lindkvist:
Title: Maria Lindkvist - Innovator in Pharmacology
Introduction:
Maria Lindkvist, a talented inventor hailing from Mölndal, Sweden, has made significant contributions to the field of pharmacology. With a keen eye for innovation, Maria has successfully patented a groundbreaking crystalline form.
Latest Patents:
Maria’s notable patent is for the crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt. This invention holds promise for the treatment of gastrointestinal disorders, paving the way for novel pharmaceutical compositions.
Career Highlights:
Currently employed at AstraZeneca AB, Maria Lindkvist continues to drive advancements in pharmaceutical research. Her dedication to pushing boundaries and exploring new possibilities exemplifies her commitment to innovation in the industry.
Collaborations:
Maria has had the privilege of collaborating with esteemed colleagues such as Lars Lilljequist and Peter Nordberg. Through their collective efforts, they have brought forth cutting-edge solutions that have the potential to revolutionize the pharmaceutical landscape.
Conclusion:
In conclusion, Maria Lindkvist stands out as a trailblazer in the realm of pharmacology. Her visionary work and pioneering spirit serve as an inspiration to aspiring inventors and researchers worldwide. With a patent that holds great promise for the future of medicine, Maria continues to make remarkable strides in the field of pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile